BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8218856)

  • 1. Stimulation of tissue type plasminogen activator by leukaemic cell homogenates.
    Wada H; Kumeda Y; Ogasawara Z; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Kageyama S; Kobayashi T
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):591-7. PubMed ID: 8218856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: clinicopathologic correlations.
    Francis RB; Seyfert U
    J Lab Clin Med; 1987 Nov; 110(5):541-7. PubMed ID: 3117952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
    Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation.
    Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
    Am J Hematol; 1991 Mar; 36(3):176-83. PubMed ID: 1899963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia.
    Sakata Y; Murakami T; Noro A; Mori K; Matsuda M
    Blood; 1991 May; 77(9):1949-57. PubMed ID: 1708294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.
    Fukao H; Ueshima S; Okada K; Yamamoto K; Matsuo T; Matsuo O
    Thromb Res; 1992 Oct; 68(1):57-65. PubMed ID: 1280377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluctuations of tissue-type plasminogen activator.plasminogen activator inhibitor-1 complex in patients with DIC].
    Nagaizumi K; Kuroso K; Amano K; Sato T; Fukutake K; Fujimaki M
    Rinsho Byori; 1994 Jul; 42(7):707-12. PubMed ID: 8065036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disseminated intravascular coagulation (DIG) with massive hyperfibrinolysis in metastatic uterine cancer. Observations on the effects on the coagulopathy of various treatments (a case report)].
    Weltermann A; Mitterbauer GJ; Mitterbauer M; Hattey E; Speiser W; Gisslinger H; Knöbl P; Eichinger S
    Wien Klin Wochenschr; 1998 Jan; 110(2):53-7. PubMed ID: 9531680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in levels of t-PA and alpha 2PI-plasmin complex in plasma in patients with DIC.
    Matsuda T; Asakura H; Ito K; Saito M; Jokaji Y; Uotani C; Kumabashiri I
    Thromb Res Suppl; 1988; 8():143-51. PubMed ID: 3144764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasminogen activator in leukemic cell homogenate].
    Wada H; Ogasawara Z; Kumeda Y; Tamaki S; Tanigawa M; Takagi M; Iwasaki E; Mori Y; Deguchi A; Tsukada T
    Rinsho Ketsueki; 1990 Nov; 31(11):1794-9. PubMed ID: 2287063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
    Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
    Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
    Wada H; Sakuragawa N; Shiku H
    Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
    Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.
    Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D
    Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogenolysis in thrombotic thrombocytopenic purpura.
    Kakishita E; Koyama T; Higuchi M; Kunitomi O; Oura Y; Nagai K
    Am J Hematol; 1989 Sep; 32(1):14-9. PubMed ID: 2502913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activators and their inhibitors in leukemic cell homogenates.
    Wada H; Kumeda Y; Ogasawara Z; Ohiwa M; Kaneko T; Tamaki S; Ohno T; Kageyama S; Kobayashi T; Deguchi K
    Am J Hematol; 1993 Feb; 42(2):166-70. PubMed ID: 8438877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostatic problems in acute leukaemia.
    Wilde JT; Davies JM
    Blood Rev; 1990 Dec; 4(4):245-51. PubMed ID: 2076471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury.
    Wada T; Gando S; Maekaw K; Katabami K; Sageshima H; Hayakawa M; Sawamura A
    Crit Care; 2017 Aug; 21(1):219. PubMed ID: 28826407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.